Latest News about MDGL
Recent news which mentions MDGL
   Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today
   
  
  
  December 19, 2022
  From Benzinga
 
   Why Is Madrigal Pharmaceuticals (MDGL) Stock Up 216% Today?
   
  
  
  December 19, 2022
  From InvestorPlace
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  December 19, 2022
  From Benzinga
 
   Tesla, Amazon, Madrigal Pharma, Pfizer, Synaptogenix: Why These 5 Stocks Are Drawing Investors' Attention Today
   
  
  
  December 18, 2022
  From Benzinga
 
   2 Healthcare Stocks Poised to Rocket Higher in the 4th Quarter
   
  
  
  November 06, 2022
  From Motley Fool
 
   10 Health Care Stocks Whale Activity In Today's Session
   
  
  
  October 28, 2022
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  October 25, 2022
  From Benzinga
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  October 17, 2022
  From Benzinga
 
   Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon
   
  
  
  September 15, 2022
  From Motley Fool
 From Benzinga
 
   Analysts Believe Madrigal's Resmetirom Shows Impressive Overall Profile In Liver Fibrosis
   
  June 27, 2022
  Tickers 
   MDGL
  
  
  From Benzinga
 From Benzinga
 
   Earnings Scheduled For May 9, 2022
   
  
  
  May 09, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Intraday Session
   
  
  
  February 03, 2022
  From Benzinga
 
   Why Madrigal Pharmaceuticals Stock Briefly Spiked Today
   
  January 31, 2022
  Tickers 
   MDGL
  
  
  From Motley Fool
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  January 31, 2022
  From Benzinga
 
   3 Biotech Stocks With Major Catalysts in January
   
  
  
  January 04, 2022
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021
   
  
  
  October 07, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
   
  
  
  October 06, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
   
  
  
  September 21, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
   
  
  
  September 17, 2021
  From Benzinga
 
   The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
   
  
  
  September 09, 2021
  From Benzinga
 
   The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
   
  
  
  August 20, 2021
  From Benzinga
 From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
